CMS will end the End-Stage Renal Disease Treatment Choices (ETC) model after studies show it did not increase home dialysis or transplant rates among Medicare patients, signaling a shift in U.S. renal care strategies.

Texas recently expanded Medigap coverage options for Medicare beneficiaries under 65 with end-stage kidney disease, improving insurance access and affordability. NKF advocacy played a key role in this policy change.